Heranba Industries Limited — Investor Meet, 27-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Financial Performance: Heranba Industries reported revenues of ₹1,075 crore for the nine months ended December 2024, up from ₹1,000 crore in the same period last year. Despite revenue growth, EBITDA was ₹117 crore, resulting in a margin of 11%. Profit after tax increased to ₹44 crore compared to ₹35 crore in the previous year, reflecting a dip in EBITDA margin mainly due to lower product realizations and rising expenses.

Future Outlook and Growth Drivers: Management views FY25 as a transitional year. They anticipate growth driven by ongoing capital expenditure (CAPEX) in Sarigam and Saykha facilities, which are expected to start commercial production by the end of FY25. Upcoming product registrations and improvements in the domestic demand landscape offer additional growth avenues.

Order Book and Operational Updates: The company is ramping up production at its new Sarigam facility (Phase 1) with Phase 2 expected to commence by the end of Q4 FY25. The Saykha facility is also set to start production in the same quarter. Management remains optimistic about expanding its product offerings to enhance the customer base.

Analyst Q&A Insights: Analysts expressed concerns about pricing pressures, particularly in the export market. Management confirmed a decline in export pricing, primarily due to low demand, but noted signs of recovery in Q4. Current capacity utilization is around 85% at existing facilities, while new sites are starting low but are expected to ramp up. Analysts were reassured by the guidance of 35% to 40% growth in FY26, alongside EBITDA margins projected at 12% to 14%.

Strategic Focus Areas: There's a clear focus on enhancing operational efficiencies and product diversification. The management believes that existing capacity will be absorbed without new CAPEX, preventing further downward pressure on prices in the industry.

Investor Insight: Given Heranba's current operational bounce-back, potential for revenue growth, and management’s positive outlook amidst market challenges, the future trajectory appears promising, suggesting a 'buy' stance for investors seeking growth in the agrochemical sector.